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and New Zealand (3–5,7). We were 
unable to confi rm the original source 
of these isolates, and continuous 
surveillance for carbapenemase 
producers in our hospital has not 
uncovered any blaOXA-181–positive 
isolates since 1996. To our knowledge, 
there are no reports of blaOXA-181–
positive isolates in Bangladesh. 
However, this country borders India, 
which is a source of blaOXA-181–positive 
Enterobacteriaceae. These cases 
highlight potential problems that may 
arise from medical tourism (the rapidly 
increasing practice of traveling across 
international borders to obtain health 
care) and document the expanding 
range of a newly emerging mechanism 
of carbapenem resistance.
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Dengue Fever 
in South Korea, 
2006–2010
To the Editor: Dengue fever is 
an acute, febrile disease caused by a 
fl avivirus and is transmitted by Aedes 
spp. mosquitoes (1). South Korea is 
not considered as a region to which 
dengue virus is endemic because it 
is located above 35°N latitude and 
has an isotherm of 10°C in winter, 
which potentially limits year-round 
survival of Aedes aegypti mosquitoes 
(1,2). Thus, dengue fever was seldom 
recognized as a public health concern 
in South Korea. However, the fi rst 
case of dengue fever in South Korea 
was reported in 1995 in a woman 
who had traveled to Sri Lanka (3). A 
second case was found in a sailor who 
had worked in countries in Africa in 
2000 (4).
Since 2001, dengue fever has 
been a notifi able infectious disease 
in South Korea because of concerns 
about increasing international travel 
as a source of infection and because 
the less effi cient potential dengue 
vector, Ae. albopictus mosquitoes, 
were found in this country. All cases 
reported through the surveillance 
system should be complemented by 
thorough epidemiologic investigations 
to determine whether a case was 
imported or originated in South 
Korea. Thus, we analyzed dengue 
fever–associated data from the Korea 
Centers for Disease Control and 
Prevention.
During 2006–2010, a total of 
367 suspected cases were reported 
by physicians through the National 
Infectious Disease Surveillance 
System. IgM ELISA and reverse tran-
scription PCR results identifi ed 324 
cases as dengue fever. Investigation 
of 34 cases could not be completed 
because some cases were in foreigners 
and in Korean persons who resided 
in foreign countries, left South Korea 
after diagnosis, or could not be reached 
by the contact information that was 
provided. Investigation of 290 cases 
was completed by reviewing medical 
records and by interviews. Interviews 
were conducted by provincial and 
Korea Centers for Disease Control 
and Prevention Epidemic Intelligence 
Service offi cers, who used a 
standardized investigation form.
All 290 case-patients had a 
history of international travel before 
onset of dengue fever symptoms. 
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Destination information was available 
for all 290 case-patients; 17 countries 
were identifi ed. Visitors to the 
Philippines (34.1%) contributed the 
largest number of cases, followed by 
visitors to Indonesia, India, Thailand, 
Vietnam, Cambodia, Laos, Malaysia, 
Myanmar, Bangladesh, China, East 
Timor, Maldives, Palau, Sri Lanka, 
Brazil, and Nigeria (Table). These 
countries are in areas to which dengue 
fever is endemic or have reported 
cases (1).
The time interval between the 
last day of travel and symptom onset 
was known for 272 (93.8%) of the 
290 case-patients. A total of 271 
case-patients had traveled within 14 
days before symptom onset, and 89 
(32.7%) had symptom onset or were 
given a diagnosis of dengue fever 
during travel. Symptoms developed 
within 7 days after travel in 171 
(62.9%) persons and 8–14 days after 
travel in 11 (4.0%) persons. Mean ± 
SD duration from the last day of travel 
to symptom onset among 182 case-
patients who had symptom onset after 
travel was 3.20 ± 2.61 days.
Our results indicate that all 
investigated case-patients had a 
history of international travel and 
times of symptom onset during or 
after travel but within the incubation 
period for dengue infection. One case-
patient had a time to symptom onset of 
<34 days. This person was eventually 
given a diagnosis of infection with 
Epstein-Barr virus but was tested for 
dengue virus. Because the incubation 
period exceeded that for dengue virus 
incubation, this case was classifi ed 
as an asymptomatic dengue virus 
infection and an Epstein-Barr virus 
infection.
Most dengue cases in South 
Korea are likely imported, and 
most presumptive countries from 
which dengue fever originated are 
in Southeast and southern Asia. 
These countries are popular holiday 
destinations for persons from South 
Korea. Because of distances, few 
tourists from South Korea travel to 
Africa and South America (5). China 
is the most popular destination for 
travelers from South Korea. However, 
the proportion of persons who 
acquired dengue infection in China 
was low (0.7%) because most persons 
who traveled to China went to Beijing 
or Shanghai, not to areas in southern 
China where dengue epidemics have 
occurred (5,6).
We report that all dengue fever 
cases in South Korea during 2006–
2010 were imported by persons who 
had traveled abroad. Global expansion 
of dengue virus and an increase in 
international travelers have increased 
the likelihood of additional cases 
of dengue fever. In addition, Ae. 
albopictus mosquitoes have been 
detected in South Korea and can 
potentially transmit autochthonous 
dengue infection, as reported in 
Croatia, France, and Hawaii, USA (7–
9). Thus, more intensifi ed surveillance 
and investigations should be focused 
on dengue transmission by Ae. 
albopictus mosquitoes in South Korea.
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Table. Presumptive country of origin of imported dengue fever cases, South Korea, 
2006–2010 
Region, country  No. (%) 
Southeast Asia 242 (83.4) 
 The Philippines 99 (34.1) 
 Indonesia 37 (12.8) 
 Thailand 30 (10.3) 
 Vietnam 24 (8.3) 
 Cambodia 17 (5.9) 
 Laos 6 (2.1) 
 Malaysia 5 (1.7) 
 Myanmar 5 (1.7) 
 East Timor 2 (0.7) 
 Palau 1 (0.3) 
 Other 16 (5.5) 
Southern Asia 40 (13.8) 
 India 32 (11.0) 
 Bangladesh 4 (1.4) 
 Maldives 2 (0.7) 
 Sri Lanka 1 (0.3) 
 Other 1 (0.3) 
Eastern Asia 
 China 2 (0.7) 
Africa
 Nigeria 1 (0.3) 
South America 
 Brazil 1 (0.3) 
Other 4 (1.4) 
Total 290 (100) 
LETTERS
  2.  Tabachnick WJ, Powell JR. A world-
wide survey of genetic variation in the 
yellow fever mosquito, Aedes aegypti. 
Genet Res. 1979;34:215–29. http://dx.doi.
org/10.1017/S0016672300019467
  3.  Kim H, Lee C, Kim M. A case of imported 
dengue hemorrhagic fever [in Korean]. 
Korean Journal of Infectious Diseases. 
1995;27:403–6.
  4.  Kwon S, Cho B, Yoon S, Cho Y, Kim I, 
Chung M, et al. A case of dengue hem-
orrhagic fever imported from Africa [in 
Korean]. Korean Journal of Infectious 
Diseases. 2000;32:467–9.
  5.  Korea Tourism Organization. 2008 Sur-
vey for international travel in Koreans [in 
Korean]. Korean Tourism Organization, 
2009 [cited 2012 May 15]. http://korean.
visitkorea.or.kr/kor/t2Main.kto?func_
name=t2main
  6.  Wu JY, Lun ZR, James AA, Chen XG. 
Dengue fever in mainland China. Am J 
Trop Med Hyg. 2010;83:664–71. http://
dx.doi.org/10.4269/ajtmh.2010.09-0755
  7.  Gjenero-Margan I, Aleraj B, Krajcar D, 
Lesnikar V, Klobučar A, Pem-Novosel 
I, et al. Autochthonous dengue fever in 
Croatia, August–September 2010. Euro 
Surveill. 2011;16: pii: 19805.
  8.  La Ruche G, Souarès Y, Armengaud A, 
Peloux-Petiot F, Delaunay P, Desprès P. 
First two autochthonous dengue virus 
infections in metropolitan France, Sep-
tember 2010. Euro Surveill. 2010;15: pii: 
19676.
  9.  Effl er PV, Pang L, Kitsutani P, Vorndam 
V, Nakata M, Ayers T, et al. Dengue fever, 
Hawaii, 2001–2002. Emerg Infect Dis. 
2005;11:742–9.
Address for correspondence: Dong-Woo Lee, 
Epidemic Intelligence Service, Division of 
Public Health Crisis Responses, Korea Centers 
for Disease Control and Prevention, 187 
Osongsaengmyeong 2(i)-ro, Cheongwon-gun, 




To the Editor: Brucellosis is a 
highly contagious bacterial disease and 
one of the world’s major zoonoses. It 
is responsible for enormous economic 
losses in livestock, and it threatens 
human health and wildlife populations 
(1). In most host species, brucellosis 
primarily affects the reproductive 
system, leading to concomitant loss 
in productivity of affected animals 
(1). Brucellae have been found in 
wildlife, such as bison, elk, and wild 
boar, potentially posing a threat for 
zoonosis (2). Currently, the genus 
Brucella comprises 10 species, 
which are divided according to host 
specifi city and ability to cause chronic 
infections in human and animals (3,4). 
Most Brucella species are associated 
primarily with certain hosts, 
presumably the result of evolutionary 
adaptation to a successful host. 
Brucella melitensis is the species most 
pathogenic in humans and the species 
most commonly involved in ovine and 
caprine brucellosis.
In January 2009, in the nature 
reserve in Qinling Mountains, China, 
hygromas were found on the knees, 
stifl es, hocks, haunches, and bursae 
between the nuchal ligament and the 
primary thoracic spines of 10 free-
ranging takins (Budorcas taxicolor). 
The hygroma contents and tissue 
samples were collected by using 
aseptic technique, packed separately, 
cooled immediately, and stored frozen 
at -20°C until cultured. The samples 
were streaked onto blood agar and 
MacConkey agar and incubated 
aerobically or anaerobically with 5% 
CO2 at 37°C for 4 days.
Tiny gram-negative coccobacilli 
were isolated. The organism was 
nonmotile at 20°C and 37°C, 
and it stained red with the Stamp 
modifi cation of the Ziehl-Neelsen 
method. The organism was identifi ed 
as B. melitensis by the Vitek 2 GN 
identifi cation system (bioMérieux, 
Marcy l’Étoile, France). The isolate 
was urease positive, catalase positive, 
and oxidase positive. It did not require 
carbon dioxide for growth and did 
not produce hydrogen sulfi de. The 
isolate could be agglutinated by 
A-monospecifi c antiserum but not by 
M-monospecifi c antiserum or rough 
Brucella-specifi c antiserum. It was 
sensitive to Berkeley and Iz phages at 
routine test dilution but not sensitive 
to Tbilisi, Weybridge, Firenze, and 
R/C phages. According to classical 
biotyping methods, the isolate was 
identifi ed as B. melitensis biotype 2 
(5).
Molecular identifi cation by 
16S rRNA gene sequencing was 
used in this study (6). According 
to nucleotide–nucleotide GenBank 
search by using BLAST (http://blast.
ncbi.nlm.nih.gov/), the sequence was 
100% identical to the sequences of 
16S rDNA of brucellae, especially 
reference strains including B. 
melitensis 16M (GenBank accession 
no. NC_003317), B. abortus biovar 1 
str. 9–941 (NC_006932), B. suis 1330 
(NC_004310), B. canis American 
Type Culture Collection 23365 
(NC_010103), and B. ovis American 
Type Culture Collection 25840 
(NC_009505). The isolate was further 
confi rmed as B. melitensis according 
to the 731-bp product by using AMOS-
PCR, which discriminates among 
species by the unique locations of the 
IS711 element (7,8). The restriction 
pattern of the omp2b gene by Hinf I 
was accordant with pattern 3 reported 
by Cloeckaert et al. (9); this fi nding 
further indicated that the isolate was 
B. melitensis (9).
The takin (Budorcas taxicolor) 
is a ruminant belonging to the family 
Bovidae, subfamily Caprinae, genus 
Budorcas (Figure). Takins are found 
in eastern Asia and Southeast Asia and 
are listed as “vulnerable A2cd” by the 
International Union for Conservation 
of Nature (10). Brucellosis might pose 
a major direct or indirect threat to the 
conservation of endangered species, 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 9, September 2012 1527
